Rigel Pharmaceuticals Inc (RIGL) — Cash Flow Quality Index
Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow Quality Index of 0.31x as of March 2026. Operating cash flow of $2.73 Million is below net income of $8.65 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore RIGL total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Rigel Pharmaceuticals Inc Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for Rigel Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Rigel Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Rigel Pharmaceuticals Inc (2010–2025)
Year-by-year earnings quality comparison for Rigel Pharmaceuticals Inc. For live market cap and the full company financial profile, see RIGL company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $75.66 Million | $367.02 Million | ▼ -88.5% |
| 2024 | 1.80x | $31.47 Million | $17.48 Million | ▲ +45.9% |
| 2010 | 1.23x | $46.74 Million | $37.89 Million | — |